Shenzhen – September 10, 2026 -- i2Cool Shenzhen Limited has closed a Series B financing round worth tens of millions of yuan, equivalent to several million US dollars, backed by Shenzhen TopoScend Capital Co., Ltd., with Linglu Capital acting as exclusive financial adviser.

The company, which develops electricity-free passive radiative cooling materials, will use the proceeds to build standardized nanoparticle production lines, advance core technology, recruit key talent, and expand commercially in priority global markets.

Los Angeles – September 10, 2026 -- Schall, Brown & Schwartz LLP (SBS) has issued a reminder to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of a securities class action lawsuit alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lead plaintiff deadline is set for September 28, 2026.

Lawsuit covers CAPR shares purchased between December 17, 2025 and July 26, 2026

The class action targets investors who purchased Capricor shares during this roughly seven-month window. Appointment as lead plaintiff is not a prerequisite for shareholders to participate in any eventual recovery.

Los Angeles – September 10, 2026 -- Schall, Brown & Schwartz LLP has filed a class action lawsuit against Blaize Holdings, Inc. (NASDAQ: BZAI), alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lawsuit covers investors who purchased BZAI shares between July 18, 2025 and April 28, 2026, with a lead plaintiff filing deadline set for October 5, 2026.

Complaint alleges Blaize recognized revenue from entities lacking meaningful business activity

According to the complaint, Blaize created an appearance of growth by announcing transactions with counterparties that were not capable of meaningful business operations. The company then improperly recognized revenue from these arrangements, rendering its public statements throughout the class period false and materially misleading, the filing states.

Frankfurt – September 10, 2026 -- Rising energy and fuel prices are changing consumer behavior in Germany but failing to trigger a rapid shift toward climate-friendly energy solutions, according to a new BearingPoint survey. The management and technology consultancy found that 53% of respondents plan no switch to greener mobility or heating options over the next two years, leaving fossil fuel infrastructure under sustained demand for longer than markets anticipated.

Higher prices cut driving but stop short of triggering investment

The survey shows 38% of respondents report driving less due to energy and fuel price increases over the past twelve months. Around a quarter shifted to alternatives: 11% use public transport more often, 13% cycle more, and 4% use electric vehicles more frequently. Meanwhile, 42% say price increases had no effect on their mobility behavior at all.

Yongin, South Korea – September 10, 2026 -- GCCL (Global Clinical Central Lab), a South Korea-based clinical trial sample analysis provider, served as a Platinum Sponsor at the Asia Bio Partnering Forum 2026 (ABP 2026) in Singapore, held from August 31 to September 2, as it pursued expansion of its assay development and sample analysis services across the Asia-Pacific region.

ABP 2026 drew 650 industry professionals and 2,500 one-on-one partnering meetings

The forum brought together approximately 650 pharmaceutical and biotechnology executives, investors and life sciences stakeholders, with roughly 2,500 one-on-one partnering meetings held over three days. GCCL used the event to hold discussions with drug developers, contract research organizations (CROs) and regional stakeholders from Korea, China, Japan, Singapore, Vietnam and Europe.

Stockholm – September 10, 2026 -- Autoliv, Inc. (NYSE: ALV) has onboarded Toyota as the first customer for its new Human Body Model (HBM) Safety Suite, a virtual crash-testing platform designed to accelerate vehicle safety development.

Toyota begins evaluating Autoliv's virtual crash simulation platform

Toyota has started using the HBM Safety Suite to assess its capabilities as part of its own virtual safety development activities, according to Autoliv. The platform combines an advanced Human Body Model -- a detailed digital representation of human anatomy -- with dedicated software for analysis, visualization, and decision-making during crash simulations.

Milton Keynes, England – September 10, 2026 -- Rockwell Automation has launched a new cybersecurity-focused season of its ROKStudios video series, as fresh data shows nearly half of manufacturers reported a cyber incident in the past year.

Rising IT/OT convergence drives operational risk for manufacturers

The new season, drawing on Rockwell's 11th Annual State of Smart Manufacturing Report, documents how increasing connectivity between IT and operational technology environments is expanding the attack surface for industrial operators. The company states that cyber risk has shifted from an episodic concern to an ongoing operational requirement as manufacturers scale AI, automation and connected systems.

Seoul – – September 10, 2026 -- LX Pantos has completed a cross-border defense logistics project transporting air-to-air missiles (AAM) from France to South Korea for the Marine Attack Helicopter (MAH) program run by the Republic of Korea Marine Corps under the Defense Acquisition Program Administration (DAPA).

The project was executed on behalf of Korea Aerospace Industries (KAI), with the missiles supplied by an unnamed European defense contractor.

Charter flight moved missiles from Châteauroux to Incheon as sole cargo

LX Pantos organized a dedicated charter flight from Châteauroux airport in France to Incheon International Airport, carrying the AAM as the only cargo aboard the aircraft to maximize security. The shipment was then transported by road to a Republic of Korea Marine Corps unit in Pohang.

Los Angeles – September 10, 2026 -- DJS Law Group has reminded shareholders of a class action lawsuit filed against Beta Bionics, Inc. (NASDAQ: BBNX) alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The suit covers investors who purchased BBNX shares between July 30, 2025 and February 24, 2026, with a lead plaintiff filing deadline set for November 3, 2026.

Complaint alleges Beta Bionics downplayed FDA findings on its iLet insulin pump

The complaint centers on the iLet Bionic Pancreas insulin pump, Beta Bionics' sole commercialized product. After the company disclosed that the FDA had issued a Form 483 following a manufacturing facility inspection, defendants allegedly told investors the agency's observations were limited to complaint-reporting criteria and did not reflect underlying device problems.

Los Angeles – – September 10, 2026 -- Schall, Brown & Schwartz LLP has filed a federal securities class action against Beta Bionics, Inc. (NASDAQ: BBNX), alleging the company misled investors about FDA findings tied to its iLet Bionic Pancreas insulin pump. The case, Holtzman v. Beta Bionics, Inc. et al., No. 2:26-cv-09999, is pending in the U.S. District Court for the Central District of California.

Class period spans July 2025 to February 2026 amid disputed FDA findings

The class covers purchasers of Beta Bionics common stock between July 30, 2025 and February 24, 2026. Investors face a November 3, 2026 deadline to seek appointment as lead plaintiff.